NUZ 0.00% 23.0¢ neurizon therapeutics limited

Ann: Research Collaboration & Joint Patent with Japanese Company, page-66

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 291 Posts.
    lightbulb Created with Sketch. 10
    Both the human and dog trials are ongoing with patients recruited along the way. Hopefully we will get an update on the first canine subjects in coming weeks given the started treatment early last month and the company indicated it would provide reports as the trials progressed.

    i wonder whether any more human subjects have been recruited?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.